New Generation Antipsychotic Drugs and QTc Interval Prolongation

AUTOR(ES)

Vieweg, W. Victor R.

FONTE

Physicians Postgraduate Press

RESUMO

Background: Recent regulatory and clinical concerns have brought into sharp focus antipsychotic drug-induced QTc interval prolongation, torsades de pointes, and sudden cardiac death. Several new generation (atypical) antipsychotic drugs have either been withdrawn from clinical use or delayed in reaching the marketplace due to these concerns. Because torsades de pointes is rarely found, QTc interval prolongation serves as a surrogate marker for this potentially life-threatening arrhythmia. Current methods of calculating this electrocardiographic parameter have limitations. The primary care physician is a key member of the team managing a patient who requires administration of antipsychotic drugs. This article focuses on new generation antipsychotic drugs and principles useful to both the primary care physician and the psychiatrist.

Documentos Relacionados

• Ziprasidone and QTc Prolongation
• QRS and QTc interval prolongation in the prediction of long‐term mortality of patients with acute destabilised heart failure
• QTc Prolongation and the Use of Antipsychotics: A Case Discussion
• Antipsychotic drugs and diabetes
• New antipsychotic drugs are slightly better than older ones